ASHLEY CORKILL: Open Payments
NPI 1740683911 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 6 payments from 4 companies in 2025. Trend: 2023 $437 · 2024 $1,137 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $246 |
| Merck Sharp & Dohme LLC | 2 | $223 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| GENZYME CORPORATION | 1 | $105 |
Products named: WINREVAIR, NUCALA, FASENRA, AIRSUPRA, DUPIXENT.
Industry payments across KS — which companies pay providers there.
